Showing results (2141-2150 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 26, 2014
Low-grade gliomasDeborah A Forst, Brian V Nahed, Jay S Loeffler, et al.
The Oncologist|March 27, 2014
The European medicines agency review of bosutinib for the treatment of adult patients with chronic myelogenous leukemia: summary of the scientific assessment of the committee for medicinal products for human useZahra Hanaizi, Christoph Unkrig, Harald Enzmann, et al.
The Oncologist|March 29, 2014
Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancerBeverly Moy, Patrick Neven, Fabienne Lebrun, et al.
The Oncologist|March 29, 2014
Phase ib of sorafenib in combination with everolimus in patients with advanced solid tumors, selected on the basis of molecular targetsFrancesca Toffalorio, Gianluca Spitaleri, Chiara Catania, et al.
The Oncologist|April 24, 2014
An ethnographic study of barriers to cancer pain management and opioid availability in IndiaVirginia Lebaron, Susan L Beck, Martha Maurer, et al.
The Oncologist|May 14, 2014
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinomaBrian M Wolpin, Douglas A Rubinson, Xiaoxu Wang, et al.
The Oncologist|May 7, 2014
Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimensNandita Khera, Amy Emmert, Barry E Storer, et al.
The Oncologist|May 7, 2014
Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panelDouglas B Johnson, Kimberly H Dahlman, Jared Knol, et al.
The Oncologist|October 16, 2016
The Impact of an Educational Program on Patient Practices for Safe Use, Storage, and Disposal of Opioids at a Comprehensive Cancer CenterMaxine de la Cruz, Akhila Reddy, Vishidha Balankari, et al.
The Oncologist|October 16, 2016
Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate CancerChe-Kai Tsao, John Sfakianos, Bobby Liaw, et al.
Pageof 571